Chervu L R, Lee H B, Goyal Q, Blaufox M D
J Nucl Med. 1977 Jan;18(1):62-6.
The use of cuprous ion as a reducing agent for pertechnetate is described for the first time. The potential usefulness of a 99mTc-Cu-DTPA complex as a renal function agent was evaluated by organ distribution studies in animals and by simultaneous continuous-infusion and single-injection clearance studies. Radioiodinated iothalamate was used as a standard for the measurement of GFR. The ratio for the clearance with the new copper complex to that with iothalamate is close to unity, both for continuous infusion (0.97 +/- 0.01 s.e) and for single injection (1.05 +/- 0.03). The coefficients of correlation are similarly close to unity: 0.96 and 0.99, respectively. Dialysis of plasma samples obtained after injection of 99mTc-Cu-DTPA into bilaterally nephrectomized rats indicates that only small amounts (less than 4%) of the complex are protein-bound. These data and the low toxicity of the copper preparation in animals appear to justify its investigation for kidney function measurement and imaging in man as well as its use as a GFR agent in animal studies.
首次描述了使用亚铜离子作为高锝酸盐的还原剂。通过动物体内器官分布研究以及同时进行的连续输注和单次注射清除率研究,评估了99mTc-Cu-DTPA复合物作为肾功能显像剂的潜在效用。放射性碘标记的碘肽酸盐用作测量肾小球滤过率(GFR)的标准。对于连续输注(0.97±0.01标准误)和单次注射(1.05±0.03),新铜复合物与碘肽酸盐的清除率之比均接近1。相关系数同样接近1,分别为0.96和0.99。将99mTc-Cu-DTPA注入双侧肾切除大鼠后获得的血浆样本透析表明,只有少量(小于4%)的复合物与蛋白质结合。这些数据以及铜制剂在动物中的低毒性似乎证明了对其进行人体肾功能测量和成像研究以及在动物研究中用作GFR显像剂的合理性。